6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase.

Citation data:

European journal of medicinal chemistry, ISSN: 1768-3254, Vol: 128, Page: 168-179

Publication Year:
2017
Usage 28
Abstract Views 28
Captures 9
Readers 8
Exports-Saves 1
Social Media 2
Tweets 2
Citations 2
Citation Indexes 2
PMID:
28182989
DOI:
10.1016/j.ejmech.2017.01.041
Author(s):
Tang, Jing, Kirby, Karen A, Huber, Andrew D, Casey, Mary C, Ji, Juan, Wilson, Daniel J, Sarafianos, Stefan G, Wang, Zhengqiang
Publisher(s):
Elsevier BV
Tags:
Pharmacology, Toxicology and Pharmaceutics, Chemistry
Most Recent Tweet View All Tweets
article description
3-Hydroxypyrimidine-2,4-dione (HPD) represents a versatile chemical core in the design of inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated RNase H and integrase strand transfer (INST). We report herein the design, synthesis and biological evaluation of an HPD subtype (4) featuring a cyclohexylmethyl group at the C-6 position. Antiviral testing showed that most analogues of 4 inhibited HIV-1 in the low nanomolar to submicromolar range, without cytotoxicity at concentrations up to 100 μM. Biochemically, these analogues dually inhibited both the polymerase (pol) and the RNase H functions of RT, but not INST. Co-crystal structure of 4a with RT revealed a nonnucleoside RT inhibitor (NNRTI) binding mode. Interestingly, chemotype 11, the synthetic precursor of 4 lacking the 3-OH group, did not inhibit RNase H while potently inhibiting pol. By virtue of the potent antiviral activity and biochemical RNase H inhibition, HPD subtype 4 could provide a viable platform for eventually achieving potent and selective RNase H inhibition through further medicinal chemistry.

This article has 0 Wikipedia mention.